Kenvue Inc. (NYSE:KVUE) Shares Acquired by Joule Financial LLC

Joule Financial LLC boosted its position in Kenvue Inc. (NYSE:KVUE) by 18.4% in the 1st quarter, HoldingsChannel reports. The firm owned 28,970 shares of the company’s stock after purchasing an additional 4,496 shares during the period. Joule Financial LLC’s holdings in Kenvue were worth $695,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. SRS Capital Advisors Inc. boosted its stake in shares of Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company’s stock worth $30,000 after purchasing an additional 571 shares during the last quarter. Asset Planning Inc purchased a new position in shares of Kenvue during the fourth quarter valued at approximately $42,000. Clarity Asset Management Inc. acquired a new stake in Kenvue during the fourth quarter worth approximately $45,000. SBI Securities Co. Ltd. purchased a new stake in Kenvue in the 4th quarter worth approximately $46,000. Finally, Deseret Mutual Benefit Administrators raised its holdings in Kenvue by 29.0% in the 4th quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company’s stock valued at $54,000 after acquiring an additional 568 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

KVUE has been the topic of a number of recent analyst reports. Barclays increased their price target on Kenvue from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday, May 12th. UBS Group increased their target price on Kenvue from $24.00 to $25.00 and gave the stock a “neutral” rating in a research report on Friday, May 9th. Evercore ISI began coverage on Kenvue in a report on Monday, March 24th. They issued an “in-line” rating and a $25.00 price target for the company. Redburn Atlantic started coverage on shares of Kenvue in a research note on Thursday, April 10th. They set a “neutral” rating and a $23.50 price objective for the company. Finally, Piper Sandler raised their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a research report on Monday, February 24th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $25.33.

Kenvue Stock Performance

Shares of NYSE:KVUE opened at $21.73 on Friday. The business has a 50-day moving average of $23.16 and a two-hundred day moving average of $22.60. The firm has a market capitalization of $41.69 billion, a PE ratio of 41.00, a P/E/G ratio of 2.62 and a beta of 0.98. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $25.17.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. The business had revenue of $3.74 billion during the quarter, compared to analysts’ expectations of $3.69 billion. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. The company’s revenue for the quarter was down 3.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.28 EPS. As a group, research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th were paid a dividend of $0.205 per share. The ex-dividend date of this dividend was Wednesday, May 14th. This represents a $0.82 annualized dividend and a yield of 3.77%. Kenvue’s dividend payout ratio is currently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.